AGC
LLY icon

ARP Global Capital’s Eli Lilly LLY Stock Holding History

ARP Global Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.9M Buy
28,295
+22,760
+411% +$23.3M 14.63% 1
2026
Q1 		$5.09M Sell
5,535
-10,305
-65% -$10.4M 2.99% 11
2025
Q4 		$17M Buy
+15,840
New +$15.1M 5.14% 6

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ARP Global Capital's LLY Position: Q2 2026 in Review

ARP Global Capital increased its Eli Lilly (LLY) stake by 411% in Q2 2026, buying an estimated $23.3M and bringing the position to 28,295 shares worth $33.9M. The position accounts for 14.63% of the portfolio, ranked #1.

ARP Global Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ARP Global Capital held 28,295 shares of Eli Lilly worth $33.9M as of Q2 2026.
  • ARP Global Capital bought 22,760 Eli Lilly shares in Q2 2026, an estimated $23.3M.
  • Eli Lilly made up 14.63% of ARP Global Capital's portfolio in Q2 2026, its #1 holding.
  • ARP Global Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ARP Global Capital's 13F filing for Q2 2026, filed 14 Aug 2026.